Resources

Autoimmune encephalitis update February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4022229/

Learn more
Treating seizures and preventing amnesia in LGI1-antibody encephalitis February 27, 2021

http://nn.neurology.org/content/2/6/e182

Learn more
Cognitive behavioral therapy after acquired brain injury: maintenance of therapeutic benefits at 6 months post-treatment February 27, 2021

https://www.ncbi.nlm.nih.gov/pubmed/22411108

Learn more
Hyponatremia and voltage gated potassium channel antibody associated limbic encephalitis February 27, 2021

https://www.omicsonline.org/open-access/hyponatremia-and-voltage-gated-potassium-channel-antibody-associated-limbic-encephalitis-2155-9562-5-195.php?aid=24048

Learn more
Paraneoplastic syndromes and autoimmune encephalitis, Five new things February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3613202/

Learn more
“Light switch” mental status changes and irritable insomnia are two particularly salient features of anti-NMDA receptor antibody encephalitis. February 27, 2021

https://www.ncbi.nlm.nih.gov/pubmed/24938143

Learn more
Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3563251/

Learn more
Utility and safety of rituximab in pediatric autoimmune and inflammatory CNS disease. February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4117174/

Learn more
Neuropsychiatric autoimmune encephalitis without VGKC-complex, NMDAR, and GAD autoantibodies: case report and literature review February 27, 2021

https://journals.lww.com/cogbehavneurol/Abstract/2013/03000/Neuropsychiatric_Autoimmune_Encephalitis_without.7.aspx

Learn more
Successful Treatment of Anti-Caspr2 Syndrome by Interleukin 6 Receptor Blockade Through Tocilizumab February 27, 2021

https://jamanetwork.com/journals/jamaneurology/fullarticle/1697440

Learn more